Solid Biosciences (SLDB) announced the appointment of Kevin Tan, CFA, a seasoned industry professional, as Chief Financial Officer, CFO. Tan brings more than 20 years of financial experience to Solid, most recently as CFO at Selecta Biosciences (SELB). In this role, Tan was responsible for all financial functions, business development activities and investor relations.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on SLDB:
- Solid Biosciences Reports Inducement Grant to Chief Financial Officer and Treasurer
- Solid Biosciences Appoints Kevin Tan, CFA, as Chief Financial Officer
- Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Solid Biosciences closes acquisition of AavantiBio, $75M private placement
- Solid Biosciences stockholders approve acquisition of AavantiBio
